TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Tonix Pharmaceuticals Announces U.S. Commercial Availability of TONMYA™ (cyclobenzaprine HCl sublingual tablets) as a First-in-Class Fibromyalgia Treatment

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Announces U.S. Commercial Availability of TONMYA™ (cyclobenzaprine HCl sublingual tablets) as a First-in-Class Fibromyalgia Treatment

Tonix Pharmaceuticals launched TONMYA, the first FDA-approved fibromyalgia treatment in over 15 years, offering a novel, non-opioid, once-daily bedtime analgesic for the estimated 10 million adults suffering from the chronic pain disorder.

Insights
MSFT   neutral

Mentioned in title, no specific details provided in article


TNXP   positive

Successfully launched a first-in-class treatment for fibromyalgia after FDA approval, representing significant medical innovation and potential market opportunity